MedTrace Logo

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical

NCT05296889 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-03-31

No results posted yet for this study

Summary

Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications

Conditions

  • Spine Fracture
  • Degenerative Disc Disease
  • Spinal Instability
  • Spinal Tumor
  • Degenerative Myelopathy

Interventions

DEVICE

posterior stabilization for the cervical spine

The Ennovate® Cervical Spinal System is a posterior stabilization for the cervical and upper-thoracic spine. The implants are used for the posterior monosegmental and multisegmental stabilization of the occipitocervical junction and of the cervical and upper thoracic spine.

Sponsors & Collaborators

  • Raylytic GmbH

    collaborator INDUSTRY

  • Aesculap AG

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-21
Primary Completion
2026-06-30
Completion
2026-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05296889 on ClinicalTrials.gov